The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFragrant Prosp. Regulatory News (FPP)

  • This share is currently suspended. It was suspended at a price of 0.516

Share Price Information for Fragrant Prosp. (FPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.516
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.516
FPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Expansion of investment mandate

24 Feb 2021 07:00

RNS Number : 1208Q
Fragrant Prosperity Holdings Ltd
24 February 2021
 

24 February 2021



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN. 

Fragrant Prosperity Holdings Limited

("FPP" or the "Company")

 

Expansion of investment mandate

 

Fragrant Prosperity Holdings Limited (the "Company") was originally listed on the London Stock Exchange's Main Market to seek to acquire a target company or business with a particular focus on the financial services sector. Whilst the Company continues to assess targets in this sector, it is now announcing today a broadening of its investment horizon to the medicinal cannabis and CBD Wellness sectors.

 

The Board has noted the guidance last year from the Financial Conduct Authority regarding admission of medicinal cannabis companies and cannabis oil companies to the Official List and the subsequent listings on the standard segment of the Official List of the Israeli based Kanabo Group plc and the internationally based MGC Pharmaceuticals Ltd. Given the international connections of the board, this has led to the Company being presented with a number of investment opportunities in the medicinal cannabis and CBD Wellness Sector both in the UK and overseas. To date the Company has not taken these forward but the Board has decided that in addition to opportunities in the financial services sector it will begin to actively consider opportunities in medicinal cannabis and CBD Wellness and has selected UK counsel with experience in listing cannabis businesses in the UK to assist with this process. Additionally, the Company is considering appointing one or more new directors with experience in the pharmaceutical and therapeutics fields in order to assist with the evaluation of possible opportunities. The Company is in advanced discussions with several potential director candidates but no agreement has yet been reached. The Company will update the market in due course.

 

The Company since joining the market has been continually evaluating potential investments and is currently considering a number of opportunities. However, discussions in respect of these opportunities are at a very early stage and no agreement has been made with any of the relevant target companies or businesses. Therefore, there is no certainty that any of the current discussions will progress further and/or result in the Company concluding a transaction.

 

*Ends*

 

 

For more information: http://www.fragrantprosperityholdings.com/

 

Fragrant Prosperity Holdings Limited

Simon Retter/Craig Marshak

+44 (0) 20 3137 1902

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTIMBTMTJTMJB
Date   Source Headline
16th Apr 20214:41 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
16th Apr 20212:05 pmRNSSecond Price Monitoring Extn
16th Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20212:05 pmRNSSecond Price Monitoring Extn
8th Apr 20212:00 pmRNSPrice Monitoring Extension
6th Apr 202111:06 amRNSSecond Price Monitoring Extn
6th Apr 202111:01 amRNSPrice Monitoring Extension
29th Mar 20219:00 amRNSPrice Monitoring Extension
29th Mar 20217:00 amRNSAppointment of Director
17th Mar 20212:05 pmRNSSecond Price Monitoring Extn
17th Mar 20212:00 pmRNSPrice Monitoring Extension
2nd Mar 202111:05 amRNSSecond Price Monitoring Extn
2nd Mar 202111:00 amRNSPrice Monitoring Extension
2nd Mar 20219:05 amRNSSecond Price Monitoring Extn
2nd Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20214:40 pmRNSSecond Price Monitoring Extn
1st Mar 20214:35 pmRNSPrice Monitoring Extension
1st Mar 20219:05 amRNSSecond Price Monitoring Extn
1st Mar 20219:00 amRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSEquity Fundraise
26th Feb 20219:06 amRNSSecond Price Monitoring Extn
26th Feb 20219:00 amRNSPrice Monitoring Extension
24th Feb 20217:00 amRNSExpansion of investment mandate
12th Feb 20214:40 pmRNSSecond Price Monitoring Extn
12th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20214:41 pmRNSSecond Price Monitoring Extn
9th Feb 20214:35 pmRNSPrice Monitoring Extension
9th Feb 20212:06 pmRNSSecond Price Monitoring Extn
9th Feb 20212:01 pmRNSPrice Monitoring Extension
12th Jan 20217:00 amRNSHalf-year Report
17th Aug 20207:50 amRNSAnnual Financial Report
8th Jun 20207:50 amRNSConvertible Loan Notes and grant of Options
20th Dec 20197:00 amRNSResult of AGM
16th Dec 20197:00 amRNSIssue of Convertible Loan Notes&Change of Director
25th Nov 20198:34 amRNSHalf-year Report
21st Nov 20197:00 amRNSNotice of AGM
15th Nov 20199:23 amRNSDirectorate Change
12th Nov 20197:00 amRNSAnnual Financial Report
15th Jul 20199:20 amRNSIssue of Equity
17th Jun 20199:07 amRNSIssue of Equity
13th Jun 20199:39 amRNSDirectorate Change
14th Jan 20198:02 amRNSHalf-year Report
1st Oct 20188:57 amRNSResult of AGM
29th Aug 201810:16 amRNSNotice of AGM
21st Aug 20189:57 amRNSFinal Results
15th Aug 20187:20 amRNSHolding(s) in Company
4th Jul 20187:46 amRNSDirectorate Change
28th Mar 201810:52 amRNSDirectorate Change
15th Jan 20181:42 pmRNSHolding(s) in Company - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.